- Home
- SOR vs ZBIO Comparison
SOR vs ZBIO Comparison
Compare SOR & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOR
- ZBIO
- Stock Information
- Founded
- SOR 1968
- ZBIO 2019
- Country
- SOR United States
- ZBIO United States
- Employees
- SOR N/A
- ZBIO N/A
- Industry
- SOR Investment Managers
- ZBIO
- Sector
- SOR Finance
- ZBIO
- Exchange
- SOR Nasdaq
- ZBIO NYSE
- Market Cap
- SOR 348.3M
- ZBIO 389.2M
- IPO Year
- SOR N/A
- ZBIO 2024
- Fundamental
- Price
- SOR $42.46
- ZBIO $9.61
- Analyst Decision
- SOR
- ZBIO Strong Buy
- Analyst Count
- SOR 0
- ZBIO 7
- Target Price
- SOR N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- SOR 16.2K
- ZBIO 132.9K
- Earning Date
- SOR 01-01-0001
- ZBIO 05-15-2025
- Dividend Yield
- SOR 7.24%
- ZBIO N/A
- EPS Growth
- SOR N/A
- ZBIO N/A
- EPS
- SOR 6.50
- ZBIO N/A
- Revenue
- SOR N/A
- ZBIO $15,000,000.00
- Revenue This Year
- SOR N/A
- ZBIO N/A
- Revenue Next Year
- SOR N/A
- ZBIO N/A
- P/E Ratio
- SOR $6.41
- ZBIO N/A
- Revenue Growth
- SOR N/A
- ZBIO N/A
- 52 Week Low
- SOR $36.41
- ZBIO $5.83
- 52 Week High
- SOR $42.75
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- SOR 54.81
- ZBIO N/A
- Support Level
- SOR $41.93
- ZBIO N/A
- Resistance Level
- SOR $43.18
- ZBIO N/A
- Average True Range (ATR)
- SOR 0.67
- ZBIO 0.00
- MACD
- SOR -0.02
- ZBIO 0.00
- Stochastic Oscillator
- SOR 51.61
- ZBIO 0.00
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.